small molecule

LORTAB

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Loss of exclusivity—loss of exclusivity

CompanyUCB →See this company's full patent-cliff portfolio

Drug detail

Brand name	LORTAB
Active ingredient	ACETAMINOPHEN; HYDROCODONE BITARTRATE
Strength	500MG;10MG
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	January 1996
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.